Peptide Search System for Immunotherapy Using Multi-Algorithm Screening
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current computational tools face challenges in efficiently identifying qualified peptides that can be presented by specific MHC proteins for immunotherapy, particularly due to the high cost and time-consuming nature of exhaustive screening, especially for MHC proteins with limited experimental data.
Innovation Solution
A system employing a deep neural network, Variational Autoencoder (VAE), Monte Carlo Tree Search (MCTS), Bayesian Optimization search with VAE (BO-VAE), Backpropagation search with VAE (BP-VAE), and sampling from a Position Weight Matrix (sPWM) to generate and screen peptide vaccine candidates for immunotherapy.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If exhaustive screening of peptide candidates is performed to identify qualified peptides for MHC presentation, then the reliability of peptide identification is improved, but the time and cost required increases significantly
Solution Approach 1:
The exhaustive screening process is segmented into multiple specialized search methods (MCTS, BO-VAE, BP-VAE, sPWM), each handling different aspects of peptide candidate evaluation. This segmentation allows parallel processing and reduces the time required while maintaining comprehensive coverage of the search space.
Solution Approach 2:
The system performs preliminary actions by using deep neural networks to predict peptide-MHC binding affinity and stability before conducting full screening. This preliminary filtering reduces the candidate pool to high-probability candidates, significantly reducing subsequent screening time while maintaining identification reliability.
2Reliability
If exhaustive screening of peptide candidates is performed to identify qualified peptides for MHC presentation, then the reliability of peptide identification is improved, but the cost increases significantly
Solution Approach 1:
The system performs partial screening by focusing computational resources on the most promising peptide candidates identified through preliminary deep learning predictions. Rather than exhaustively screening all possible peptides, the system applies sophisticated search methods only to high-probability candidates, reducing computational cost while maintaining reliable identification.
Solution Approach 2:
The system uses computational models (deep neural networks, VAEs) to create virtual copies and predictions of peptide-MHC interactions, reducing the need for expensive experimental validation of every candidate. These computational proxies allow reliable screening at lower cost.
3Adaptability or versatility
If multiple search methods are employed to generate peptide candidates, then the quality and diversity of candidates is improved, but the system complexity increases
Solution Approach 1:
The system merges multiple search methods (MCTS, BO-VAE, BP-VAE, sPWM) into a unified framework that processes peptide candidates through coordinated pipelines. This merging allows the system to leverage the strengths of each method while managing complexity through integrated architecture and shared computational resources.
Solution Approach 2:
The deep neural networks and VAEs serve multiple functions across different search methods, acting as universal components that provide predictions and representations used by MCTS, BO-VAE, BP-VAE, and sPWM. This multi-functionality reduces overall system complexity despite employing diverse search strategies.
Data Source
AI summary
A system for binding peptide search for immunotherapy is presented. The system includes employing a deep neural network to predict a peptide presentation given Major Histocompatibility Complex allele sequences and peptide sequences, training a Variational Autoencoder (VAE) to reconstruct peptides by converting the peptide sequences into continuous embedding vectors, running a Monte Carlo Tree Search to generate a first set of positive peptide vaccine candidates, running a Bayesian Optimization search with the trained VAE and a Backpropagation search with the trained VAE to generate a second set of positive peptide vaccine candidates, using a sampling from a Position Weight Matrix (sPWM) to generate a third set of positive peptide vaccine candidates, screening and merging the first, second, and third sets of positive peptide vaccine candidates, and outputting qualified peptides for immunotherapy from the screened and merged sets of positive peptide vaccine candidates.